BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 17712819)

  • 1. Human cannabinoid pharmacokinetics.
    Huestis MA
    Chem Biodivers; 2007 Aug; 4(8):1770-804. PubMed ID: 17712819
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrochemical Sensing of Cannabinoids in Biofluids: A Noninvasive Tool for Drug Detection.
    Klimuntowski M; Alam MM; Singh G; Howlader MMR
    ACS Sens; 2020 Mar; 5(3):620-636. PubMed ID: 32102542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Passive inhalation of cannabis smoke--is it detectable?].
    Westin AA; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):109-13. PubMed ID: 19151803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lipophilicity and functional groups of synthetic cannabinoids on their blood concentrations and urinary excretion.
    Kakehashi H; Shima N; Ishikawa A; Nitta A; Asai R; Wada M; Nakano S; Matsuta S; Sasaki K; Kamata H; Kamata T; Nishioka H; Miki A; Katagi M
    Forensic Sci Int; 2020 Feb; 307():110106. PubMed ID: 31902661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts.
    Grauwiler SB; Scholer A; Drewe J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):515-22. PubMed ID: 17236827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of a homogeneous enzyme immunoassay (EMIT) for cannabinoid detection in biological fluids.
    Law B; Pocock K; Moffat AC
    J Forensic Sci Soc; 1982 Jul; 22(3):275-81. PubMed ID: 6750029
    [No Abstract]   [Full Text] [Related]  

  • 8. High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.
    Zaitsu K; Nakayama H; Yamanaka M; Hisatsune K; Taki K; Asano T; Kamata T; Katagai M; Hayashi Y; Kusano M; Tsuchihashi H; Ishii A
    Int J Legal Med; 2015 Nov; 129(6):1233-45. PubMed ID: 26349566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic procedures for determination of cannabinoids in biological samples, with special attention to blood and alternative matrices like hair, saliva, sweat and meconium.
    Staub C
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):119-26. PubMed ID: 10572977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a radioimmunoassay (125I) kit for cannabinoid metabolites in urine and whole blood.
    Childs PS; McCurdy HH
    J Anal Toxicol; 1984; 8(5):220-3. PubMed ID: 6503225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ
    Newmeyer MN; Swortwood MJ; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2017 Mar; 63(3):647-662. PubMed ID: 28188235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantitation of cannabinoids in biological fluids: specificity and kinetics after smoking.
    Scherrmann JM; Hoellinger H; Nguyen-Hoang-Nam ; Boudet L; Pichon J; Do-Cao-Thang
    Clin Toxicol; 1981 May; 18(5):565-71. PubMed ID: 6268351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas chromatographic-mass spectrometric confirmation of radioimmunoassay results for cannabinoids in blood and urine.
    Clatworthy AJ; Oon MC; Smith RN; Whitehouse MJ
    Forensic Sci Int; 1990 Jul; 46(3):219-30. PubMed ID: 2376363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
    Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
    Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of cannabinoids in biological fluids.
    NIDA Res Monogr; 1982; 42():1-137. PubMed ID: 6817138
    [No Abstract]   [Full Text] [Related]  

  • 17. Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    J Pharm Biomed Anal; 2018 Feb; 150():162-168. PubMed ID: 29245085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabis and urine samples].
    Westin AA
    Tidsskr Nor Laegeforen; 2011 Mar; 131(6):577-80. PubMed ID: 21423309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis.
    Pérez-Acevedo AP; Pacifici R; Mannocchi G; Gottardi M; Poyatos L; Papaseit E; Pérez-Mañá C; Martin S; Busardò FP; Pichini S; Farré M
    Phytother Res; 2021 Mar; 35(3):1646-1657. PubMed ID: 33155722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of (synthetic) cannabinoids in pigs and their relevance for clinical and forensic toxicology.
    Schaefer N; Wojtyniak JG; Kettner M; Schlote J; Laschke MW; Ewald AH; Lehr T; Menger MD; Maurer HH; Schmidt PH
    Toxicol Lett; 2016 Jun; 253():7-16. PubMed ID: 27113702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.